Haemonetics (HAE) EBT Margin (2009 - 2026)

Haemonetics' EBT Margin history runs 18 years deep, the most recent figure standing at 8.2% for Q1 2026.

• In Q1 2026, EBT Margin fell 2960.0% year-over-year to 8.2%; the TTM figure through Mar 2026 stood at 9.6% (down 599.0% YoY), while the FY2026 annual figure was 9.6%, down 599.0% from the prior year.
• EBT Margin was 8.2% for Q1 2026 at Haemonetics, down from 17.69% in the prior quarter.
• In the past five years, EBT Margin ranged from a high of 21.4% in Q1 2025 to a low of 8.2% in Q1 2026.
• Historically, EBT Margin has averaged 11.92% across 5 years, with a median of 13.45% in 2022.
• The sharpest annual moves came in 2022 and 2026: EBT Margin jumped 1796 bps in 2022, then plunged 2960 bps in 2026.
• A 5-year view of EBT Margin shows it stood at 13.83% in 2022, then slipped by 5 bps to 13.09% in 2023, then increased by 9 bps to 14.32% in 2024, then rose by 24 bps to 17.69% in 2025, then tumbled by 146 bps to 8.2% in 2026.
• The last three EBT Margin figures came in at 8.2% (Q1 2026), 17.69% (Q4 2025), and 15.67% (Q3 2025), per Business Quant data.